Use App
New
Connect your Agent
Trending
News
Earnings
All
DIA
1.11%
SPY
0.41%
QQQ
0.02%
Trending
ZETA
13.77%
SPCX
8.38%
APPS
43.22%
DKNG
4.02%
AMD
6.97%
SHOP
17.60%
FUBO
3.14%
UBER
6.00%
BCRX
0.44%
ANET
3.80%
Feed
News
Sentiment
Earnings
Fundamentals
Info
home
Symbol
MDNAF
news
Exchange:
OTC
·
Updated 10:17 AM EDT
News
all
press releases
Medicenna Therapeutics (MDNAF) Upgraded to Buy: Here's What You Should Know
Medicenna Therapeutics (MDNAF) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Zacks
<
1
>
Advertisement
|
Remove ads.
Watchlist
Trending
News
Explore
Community
Profile